Study: biomeeTM Dry Skin successfully alleviates dry skin symptoms in 87% of participants

Amino acids found in the outermost layers of the skin are crucial to normal skin hydration and are derived from degradation of the protein filaggrin. Filaggrin mutations or suppressed filaggrin production due to inflammation can result in lack of amino acids and dry skin.

MC2 Therapeutics recently sponsored a 21-day study conducted by Dr. Christian Avnstorp at the Skin Clinic in Rødovre, Denmark (Hudklinikken i Rødovre). The study investigated and measured the efficacy of biomeeTM Dry Skin while investigating the cream’s tolerability and the subjects’ subjective assessment of the cream.

MC2 Therapeutics has formulated an innovative moisturizing cream, biomeeTM Dry Skin, using a novel formulation technology called PAD TechnologyTM and characterized by the following key features:

1. A high amino acid content
The amino acids substitute amino acids lacking in the skin of people with low levels of filaggrin.

2. Unique low emulsifier content (<0.5%)
The low level of emulsifier reduces potential “wash-out” of the protecting acid layer of free fatty acids, sebum and other lipids of the skin barrier.

3. No use of greasy wax or petrolatum
biomee products are designed for ease of use in daily routines to motivate adherence. Fast absorption, non-greasy and easy to spread are key features of biomee products.

The Study

60 adult patients participated in the open-label study, which means that both the participants and the researcher were aware that biomeeTM Dry Skin was being administered. All of the participants suffered from dry skin, with atopic dermatitis, ichthyosis vulgaris, and hand eczema being the most frequent diagnoses within the test group.

The study evaluated the cream’s hydration properties and its ability to alleviate dryness, scales and itching over the course of 21 days. The cream was applied twice daily to an area of the body with dry skin (2% of the total body surface area). The researcher scored its effect on three symptoms of dry skin:

– Dryness
– Scales
– Scratch marks

The scoring was based on a scale of 0–3 for each parameter (with 0 being no symptoms). Scores were recorded on Day 1 (baseline), Day 7, and Day 21.

The Results

54 participants finished the study. Of these, 47 (87%) were classified as “treatment success” on Day 21. “Treatment success” was defined as “improvement in at least two of the three symptoms of dry skin.”

Adverse events to the cream were minor, and 77% of the participants found the cream to be “pleasant” or “very pleasant” after application.

87% of participants were classified as “treatment success” on Day 21.

Dryness, Scaling & Scratch Marks
The graph below presents the average (i.e., mean) scores of dryness, scaling, and scratch marks on Day 1, Day 7, and Day 21.  Each of the symptoms was evaluated on a scale of 0–3.

The data shows that dryness, scaling, and scratch marks were notably reduced on Day 21.

*p<0.0001, **p=0.0007.

The following photos show a 20-year-old male with atopic dermatitis on Day 1 and Day 21 of the study.  Informed consent to publish the pictures has been obtained from the patient.

The following photos show a 56-year-old woman with ichthyosis vulgaris on the lower leg on Day 1 and Day 21 of the study. Informed consent to publish pictures has been obtained from the patient.

Itch Intensity & Sleep Disturbances
Of the 54 patients who completed the study, 45 self-reported itching while 16 also self-reported sleep disturbances. Sleep disturbances were found to be closely associated with itching. Patients who reported sleep disturbances also reported a higher average itch intensity vs. those who didn’t.

The graph below presents the average (i.e., mean) scores of itch intensity and sleep disturbances on Day 1, Day 7, and Day 21.  Patients self-evaluated each symptom on a scale of 0–10, with “0” representing no symptoms and “10” representing the worst possible symptoms.

The data shows that itch intensity and sleep disturbances were notably reduced on Day 21.

Itch intensity and related sleep disturbances were notably reduced on Day 21.

Study Conclusions

The study found biomeeTM Dry Skin to be highly effective in alleviating symptoms of dry scaling skin, itching, and related sleep disturbances. The cream was very well accepted by patients and was found to improve their quality of life.

Back

Incontinence-Associated Dermatitis (IAD)

Incontinence-associated dermatitis (IAD) is a common form of irritant contact dermatitis caused by prolonged skin contact with urine. Moisturizing and restoring the skin barrier function are vital to treating IAD.

Read More

Dry skin in children with atopic dermatitis (AD)

Atopic dermatitis (AD) causes dry skin, itch, and rash. Up to 50% of people with AD lack the natural protein filaggrin in their skin. Therefore, their skin becomes dry, cracked and prone to infections.

Read More

Dry “fish scale” skin

1 in 250 people has dry “fish scale” skin. It is caused by a lack of filaggrin – a protein that occurs naturally in the skin and plays a vital role in maintaining a healthy skin.

Read More

83.6% of people surveyed prefer biomeeTM skincare to other products

A recent survey of biomee™ customers found that 83.6% prefer biomee™ to other products for relieving symptoms like dry, itchy, and red skin related to Sjögren's, atopic dermatitis, eczema, psoriasis, and other conditions.

Read More

contact us

Would you like to know more?

Do you have any questions, or would you like to know more about our biomee™ skin care line?

You are welcome to contact us at [email protected] and we will get back to you as soon as possible.